LifeVantage Q4 revenue down 23% to $42.4M; FY revenue down 20% to $182.6M

Lifevantage Corp

2026-FY EPS reported $0.40 revenue$182,586,000

Q4 revenue $42.4M (-23.1% YoY); Americas -24.8%, APAC/Europe -16.9%.
Q4 EPS $0.10 GAAP, $0.11 adjusted; FY EPS $0.40, adj $0.56.
FY revenue $182.6M (-20.1%); gross margin 77.6% on MindBody GLP-1 obsolescence.
Adj EBITDA Q4 $2.7M vs $4.8M; FY $13.7M vs $22.1M.
No FY27 guidance due to CEO transition; repurchased 336k shares ~$2M, $58.5M left.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.